Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Colby who wrote (19804)	3/17/1999 4:12:00 PM
From: blankmind	Respond to of 23519

Today's mention of Vivus in the WSJ was significant because they now consider Vivus a "real" ED company. - Unfortunatley, the article was buried in section B; and no time mentioned when Vivus's female dysfunction drug would come out.

To: Colby who wrote (19804)	3/17/1999 4:31:00 PM
From: Little Gorilla	Read Replies (1) \| Respond to of 23519

Message 8371357 >>Before Viagra, Goldstein says, patients used to complain, "Gee, Doc, I'm impotent, and nobody will take care of me, nobody will examine me." Now, patients complain, plenty of doctors are writing Viagra prescriptions with just a cursory examination and no mention of alternative treatments, Goldstein says. He says much of his practice consists of the 30% of Viagra users who saw no improvement with the pill.<<

To: Colby who wrote (19804)	3/17/1999 6:26:00 PM
From: AlienTech	Read Replies (2) \| Respond to of 23519

>>Mario Rosati has held the position of Secretary of VIVUS since April 1991, while serving as a partner at Wilson, Sonsini, Goodrich & Rosati, a law firm that provides counsel to VIVUS. Additionally, Rosati is a member of the Board of Directors of several high technology companies. << Looks to me like Leyland aint taking any chances with the shareholder movement. Its amazing he is preparing to shoot the vladester down before he even gets the chance to stand up.